- Division of Translational and Clinical Sciences – DTCS
- Oncology 2 – Translational Clinical – OTC
- Study Section:
- Cancer Biomarkers – CBSS
Dr. Lawrence Ng serves as the Scientific Review Officer for CSR’s Cancer Biomarkers Study Section.
Dr. Ng received his Ph.D. and post-doctoral training in pharmaceutical sciences from the University of Wisconsin at Madison and the University of Kansas. Prior to coming to NIH, Dr. Ng was an associate professor and the principal investigator and co-investigator of several NIH grant awards (RO1 and R21) at the University of Colorado Health Sciences Center and the National University of Singapore, where he spearheaded drug delivery research and discovery and elucidation of mechanism of anti-cancer agents derived from natural products.